PPD
PPD is a global contract research organization that offers drug development, laboratory, and lifecycle management services.
Business Model:
Revenue: $0
Employees: 10,001-1
Industries / Tags:
Detailed PPD Information
PPD was acquired by
Thermo Fisher Scientific.
The acquisition happend on 2021-04-15.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Wilmington
State: North Carolina
Zip:
Country: United States
Financial Info
Stage:
private equity
Raised Last:
$0
Raised Total:$0
Social
Metrics
305,093Website Global Rank
225,530Website Monthly Traffic
Twitter Followers
Description
PPD is a global contract research organization (CRO) providing discovery, development, and post-approval services as well as compound partnering programs. Their clients and partners include pharmaceutical, biotechnology, medical device, academic, and government organizations. PPD applies innovative technologies, therapeutic expertise, and a firm commitment to quality to help customers bend the cost and time curve of drug development to provide life-changing therapies that improve health.
Contact Phone:
Contact Email:
PPD went public on 2/5/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/5/2020
IPO Valuation:
$9B
Ticker Symbol:
PPD
IPO Price:
$27/share
Amount Raised:
$2B
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2020 | Medable | Series C | 91M |
| 4/2021 | Medable | Series C | 0 |
| 10/2009 | Auven Therapeutics | Funding Round | 100M |
| 11/2020 | Medable | Series C | 0 |
| 8/2020 | Science 37 | Venture Round | 0 |
| 10/2021 | Science 37 | Post-IPO Equity | 0 |
| 5/2020 | Medable | Venture Round | 0 |
| 1/2019 | Science 37 | Series D | 0 |
| 10/2021 | Science 37 | Post-IPO Equity | 0 |
| 4/2021 | Medable | Series C | 0 |
| 11/2020 | Medable | Series C | 0 |
| 8/2020 | Science 37 | Venture Round | 0 |
| 5/2020 | Medable | Venture Round | 0 |
| 1/2019 | Science 37 | Series D | 0 |
| 10/2009 | Auven Therapeutics | Funding Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Name | Price |
|---|---|---|
| 8/2016 | Evidera | |
| 6/2016 | Synexus | |
| 9/2014 | X-Chem | |
| 9/2014 | RCT Logic | |
| 11/2009 | BioDuro | |
| 10/2009 | Excel PharmaStudies | |
| 4/2009 | AbCRO | |
| 4/2009 | Magen BioSciences |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
